Montelukast Mylan

Montelukast, the active ingredient in Montelukast Mylan, is a leukotriene receptor antagonist presented as a tablet for oral use. It treats asthma, allergic rhinitis, and exercise‑induced bronchoconstriction in adults and children. GNH USA supplies Montelukast Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast is a leukotriene‑blocking agent used in chronic respiratory and allergic conditions. - Asthma: improves control of persistent asthma and reduces exacerbations. - Allergic rhinitis: relieves nasal congestion, sneezing and itching caused by seasonal or perennial allergens. - Exercise‑induced bronchoconstriction: prevents airway narrowing that occurs during or after physical activity.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often reported during early therapy. - Abdominal pain: discomfort or cramping in the stomach region. - Nausea: feeling of queasiness without vomiting. - Diarrhoea: loose, watery stools. - Cough: transient irritation of the throat. - Fatigue: unusual tiredness or lack of energy.

Serious or Rare Side Effects: - Allergic reactions: rash, urticaria, or angioedema requiring medical attention. - Mood changes: depression, anxiety, or suicidal thoughts. - Hepatic enzyme elevation: abnormal liver function tests. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Eosinophilic granulomatosis with polyangiitis: rare vasculitic disorder. - Hemorrhagic events: unusual bruising or bleeding.

Montelukast should be used with awareness of specific safety considerations. - Monitor liver function: periodic testing is advised for patients with hepatic disease. - Caution in psychiatric history: observe for mood alterations or suicidal ideation. - Adjust in renal impairment: dose may need modification in severe kidney dysfunction. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use in pregnancy only if benefit outweighs risk: limited data are available. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Montelukast may interact with other medicines, requiring attention to the level of interaction.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase montelukast plasma concentrations. - Phenobarbital or rifampin: can markedly reduce montelukast effectiveness. - Warfarin: concurrent use may enhance anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase risk of neuropsychiatric events. - Beta‑agonists: additive bronchodilator effect may occur. - Theophylline: monitor for possible changes in respiratory symptoms.